Valuation: Lifestyle Delivery Systems Inc

Market Cap 10.2M 7.32M 6.34M 5.94M 5.42M 698M 10.36M 69.99M 27.32M 349M 27.46M 26.87M 1.17B P/E 2022 *
-
P/E 2023 -0.92x
Enterprise Value 9.74M 6.99M 6.06M 5.68M 5.18M 667M 9.9M 66.86M 26.1M 334M 26.23M 25.67M 1.11B EV / Sales 2022 *
-
EV / Sales 2023 43x
Free-Float
99.7%
Yield 2022 *
-
Yield 2023 -
Change 5-day change 1-year change 3-year change Capi.($)
-11.17%-38.75% - - 47
-0.18%-0.45%-9.89%-7.24% 13.37B
-0.55%-2.17%+4.13%+2.05% 5.01B
-0.16%+0.04%-31.70%-56.19% 5.06B
+1.91%+5.17%+5.88%-29.83% 4.16B
+0.19%-0.22%-13.96%-5.79% 3.66B
-0.75%-7.72%-6.65%-0.32% 3.44B
+0.78%-0.39%-5.34%+15.75% 3.39B
+0.82%+3.69%-13.70%-15.03% 2.48B
-3.91%-11.36%-14.70%+24.49% 1.71B
Average -1.30%-2.19%-9.55%-8.01% 4.7B
Weighted average by Cap. -0.05%-1.35%-9.43%-10.86%

Financials

2021 2022 *
Net sales 432K 310K 268K 252K 229K 29.55M 439K 2.96M 1.16M 14.79M 1.16M 1.14M 49.34M -
Net income -37.05M -26.58M -23.04M -21.6M -19.69M -2.54B -37.65M -254M -99.28M -1.27B -99.79M -97.63M -4.24B -
Net Debt -843K -605K -524K -492K -448K -57.74M -857K -5.79M -2.26M -28.9M -2.27M -2.22M -96.41M -
Logo Lifestyle Delivery Systems Inc
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.
Employees
-